… While another study from the United States showed higher risk of gastrointestinal bleeding
in the rivaroxaban group[23], our study yielded favorable result pointing toward reduction of …

… Standard-dose regimen was defined as dabigatran 300 mg, rivaroxaban 20 mg, apixaban
… DOACs with low-dose DOACs in patients with intermediate stroke but high bleeding risk to …

… Direct oral anticoagulants (DOACs; rivaroxaban, apixaban, edoxaban, and dabigatran) …
low-dose rivaroxaban was associated with a lowered risk of stroke/SE, bleeding (major bleeding…

… prescription for apixaban, rivaroxaban, dabigatran, or edoxaban in the preceding 180 days.
… One study found a decreased risk for major bleeding with apixaban relative to rivaroxaban. It …

… a significantly lower risk of major bleeding and equal efficacy with apixaban, … risk of stroke
and mortality compared to low dose apixaban, 2.5 mg twice a day (n = 1317) and warfarin. …

… When comparing low-dose dabigatran with low-dose rivaroxaban, we did not find significant
… increase in the major bleeding risk. For low-dose rivaroxaban vs apixaban, we did not …

… trials evaluating dabigatran, rivaroxaban, apixaban and edoxaban … The approved low dose
of 75mg BID for dabigatran was … to major bleed for all low dose DOAC group versus warfarin …

… When patients receiving high-dose diltiazem treatment were directly compared with those
receiving low-dose treatment, the HR was 1.14 (95% CI, 1.02-1.26). There was no evidence of …

… difference in safety profiles between rivaroxaban, apixaban and dabigatran. We were able to
… anticoagulation disproportionally received apixaban and dabigatran, though we note these …

… new users of apixaban, rivaroxaban, and dabigatran to new users of warfarin in a national
… Bleeding rates were higher among low dose rivaroxaban users with an indication for dose …